Jakafi 15 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKL3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,583
Award facts
- Contract value 100% obligated
- $12,582.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,582.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count units). The delivery order, issued on January 14, 2026, with an ultimate completion date of January 15, 2026, was structured as a firm fixed-price contract with no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group will perform the work at its Park Ridge, Illinois location and serve as the sole prime contractor with no identified subcontractors involved in the delivery.
This delivery order falls under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy. The underlying indefinite delivery contract, valued at $499,999,999 and awarded in November 2025, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. Through this vehicle, DMS Pharmaceutical Group functions as a critical regional pharmaceutical supplier for military medical facilities, and the issuance of this delivery order demonstrates the company's continued performance within the broader PPV-G GEN V framework for meeting recurring pharmaceutical supply needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKKL3?
SPE2DR26FKKL3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FKKL3 worth?
The government has obligated $12,583 on SPE2DR26FKKL3.
Is contract SPE2DR26FKKL3 an order under another contract?
Yes. SPE2DR26FKKL3 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKL3 competed?
The extent of competition for SPE2DR26FKKL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award